Auxier Asset Management Laboratory Corp Of America Holdings Transaction History

Auxier Asset Management

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$209.01 - $232.56 $4,180 - $4,651	-20 Reduced 2.05%	955 $208,000
Q4 2023 Feb 22, 2024	BUY	$197.69 - $227.29 $192,747 - $221,607	975 New	975 $221,000
Q1 2023 May 15, 2023	SELL	$213.32 - $257.83 $46,930 - $56,722	-220 Reduced 18.41%	975 $223,000
Q2 2022 Aug 11, 2022	SELL	$213.86 - $277.87 $1,069 - $1,389	-5 Reduced 0.42%	1,195 $280,000
Q3 2021 Nov 18, 2021	SELL	$274.82 - $308.34 $15,115 - $16,958	-55 Reduced 4.38%	1,200 $338,000
Q2 2021 Aug 18, 2021	SELL	$251.87 - $278.14 $27,705 - $30,595	-110 Reduced 8.06%	1,255 $346,000
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $2,048 - $2,550	-10 Reduced 0.73%	1,365 $348,000
Q4 2020 Mar 05, 2021	SELL	$186.91 - $214.42 $934 - $1,072	-5 Reduced 0.36%	1,375 $280,000
Q3 2020 Mar 05, 2021	SELL	$167.03 - $201.3 $835 - $1,006	-5 Reduced 0.36%	1,380 $260,000
Q2 2020 Aug 20, 2020	BUY	$113.31 - $182.44 $156,934 - $252,679	1,385 New	1,385 $230,000
Q1 2020 May 15, 2020	SELL	$104.32 - $195.28 $149,699 - $280,226	-1,435 Closed	0 $0
Q4 2019 Feb 21, 2020	SELL	$163.48 - $173.61 $1,634 - $1,736	-10 Reduced 0.69%	1,435 $243,000
Q1 2019 May 14, 2019	BUY	$123.7 - $156.3 $178,746 - $225,853	1,445 New	1,445 $221,000
Q4 2018 Feb 13, 2019	SELL	$120.82 - $174.09 $190,291 - $274,191	-1,575 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$161.53 - $178.11 $28,267 - $31,169	-175 Reduced 10.0%	1,575 $255,000
Q4 2017 Feb 14, 2018	SELL	$147.99 - $163.95 $3,699 - $4,098	-25 Reduced 1.41%	1,750 $279,000
Q2 2017 Aug 16, 2017	BUY	N/A	1,775	1,775 $274,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

Stay updated on Auxier Asset Management with notifications on news.